SOLVONIS THERAPEUTICS PLC

SolvOnis Therapeutics: 2026 Stock Review, P/E Ratio & Market Trends

SolvOnis Therapeutics PLC stock dips to 0.1 GBX with a negative P/E of –1.22, showing volatility but potential upside for investors eyeing future profitability.

SOLVONIS THERAPEUTICS PLC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

07/11/2026, 15:32

2 minutes to read